A broad stock index can appear stable even when many constituents move in the opposite direction. That is the signal in the supplied CNBC report, which cites Goldman Sachs research finding that about 45% of S&P 500 stocks had a negative three-month beta. CNBC's own calculation placed the comparable figure near 40%, with 17% showing a negative one-year beta based on weekly returns.
Beta is measured over a defined period. A negative reading indicates that a security's returns moved against the benchmark during that period; it does not mean the stock is permanently defensive or will rise whenever markets fall. The short measurement window is especially important because correlations can change quickly.
The divergence reflects index concentration. A limited set of large technology companies carries enough benchmark weight to lift index returns while smaller constituents lag or decline. The article describes a recent session when the S&P 500 gained 1.5%, yet 30 stocks reached 52-week lows against seven at new highs. That is a breadth warning, although an isolated historical comparison is not a market-timing forecast.
Investors using capitalization-weighted indexes should distinguish exposure to the index from equal exposure to the underlying companies. An index ETF can become increasingly sensitive to a handful of earnings reports or AI-capital-spending assumptions, even as apparently unrelated sectors show weak correlation with the benchmark. Conversely, negative beta over three months does not establish that laggards are undervalued.
The relevant response is analytical: review concentration, sector contribution and participation alongside the benchmark's headline return. A widening gap can create different portfolio risks than the index chart alone suggests.
What investors should watch: equal-weight versus cap-weight performance, new highs and lows, sector correlations, earnings breadth and whether the percentage of negative-beta constituents persists over longer windows.
BTI’s bottom line: index-level gains are a less complete measure of market health when company-level participation is fragmented. Breadth and concentration deserve separate monitoring.